Vertex Unveils Strong Data on Opioid Alternative

If approved, it would be the first new pain medicine in decades, and could provide an alternative to opioids.

Related Keywords

,Stuart Arbuckle ,David Risinger ,Josh Nathan Kazis ,Salveen Richter ,David Altshuler ,Drug Administration ,Vertex Pharmaceuticals ,Goldman Sachs ,Article Normal ,Pharmaceuticals ,Analgesics ,Scientific Research Services ,Healthcare Life Sciences ,Business Consumer Services ,Specialized Drugs Medications ,Medical Research Services ,Drug Discovery Development ,Healthcare Support Services ,Diagnostic Medical Research Services ,Drug Substance Use Abuse ,Adverse Drug Reactions ,Political General News ,Society Community ,Health ,Medication Abuse Misuse ,Social Issues ,Synd ,Biotech And Pharma ,Markets ,North America ,Vrtx ,Drug ,Substance Use ,Abuse ,Political ,General News ,Society ,Community ,Medication Abuse ,Misuse ,Healthcare ,Life Sciences ,Business ,Consumer Services ,Specialized Drugs ,Medications ,Drug Discovery ,Development ,Diagnostic ,